A double-blind trial of naloxone in central post-stroke pain.

Abstract

Intravenous naloxone has been claimed to produce pain relief in opioid-resistant central post-stroke pain (CPSP, 'thalamic syndrome'). In a double-blind trial, carried out in 20 patients with established CPSP, naloxone (up to 8 mg in 20 ml vehicle) was tested against normal saline; each patient was randomly given naloxone or saline and the other substance 2… (More)

Topics

Cite this paper

@article{Bainton1992ADT, title={A double-blind trial of naloxone in central post-stroke pain.}, author={Toby Bainton and Maryanne Fox and David Bowsher and Christine P. Wells}, journal={Pain}, year={1992}, volume={48 2}, pages={159-62} }